Combination of peroxisome proliferator–activated receptor gamma and retinoid X receptor agonists induces sodium/iodide symporter expression and inhibits cell growth of human thyroid cancer cells

Thyroid tumors are the most frequent neoplasm of the endocrine system. The major treatment is surgical intervention followed by radioiodine therapy. The sodium/iodide symporter (NIS) has positive expression in thyroid carcinomas with good prognoses and plays a critical role in radioiodine therapy re...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jui-Yu, Wang, Jane-Jen, Lee, Hsin-Chen, Chi, Chin-Wen, Lee, Chen-Hsen, Hsu, Yi-Chiung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526568/
https://www.ncbi.nlm.nih.gov/pubmed/33009242
http://dx.doi.org/10.1097/JCMA.0000000000000389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526568/
https://www.ncbi.nlm.nih.gov/pubmed/33009242
http://dx.doi.org/10.1097/JCMA.0000000000000389

Ejemplares similares